Drug Shortage Report for SOLYSTAT
Report ID | 29863 |
Drug Identification Number | 00769541 |
Brand name | SOLYSTAT |
Common or Proper name | SOLYSTAT 250mg/mL U.D.SUSP 60mL |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
Strength(s) | 250MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 60ml |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-12-18 |
Actual start date | 2017-12-01 |
Estimated end date | 2018-03-12 |
Actual end date | 2018-03-06 |
Shortage status | Resolved |
Updated date | 2018-03-13 |
Company comments | Limited stock available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-03-13 | French | Compare |
v10 | 2018-03-13 | English | Compare |
v9 | 2018-03-02 | French | Compare |
v8 | 2018-03-02 | English | Compare |
v7 | 2017-12-22 | French | Compare |
v6 | 2017-12-22 | English | Compare |
v5 | 2017-12-04 | French | Compare |
v4 | 2017-12-04 | English | Compare |
v3 | 2017-12-04 | English | Compare |
v2 | 2017-11-20 | French | Compare |
v1 | 2017-11-20 | English | Compare |
Showing 1 to 11 of 11